share_log

Burcon NutraScience (OTCMKTS:BUROF) Share Price Passes Below 50-Day Moving Average of $0.53

Defense World ·  Sep 7, 2022 03:41

Shares of Burcon NutraScience Co. (OTCMKTS:BUROF – Get Rating) (TSE:BU) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.53 and traded as low as $0.43. Burcon NutraScience shares last traded at $0.46, with a volume of 274,822 shares traded.

Burcon NutraScience Price Performance

The business's 50 day moving average is $0.53 and its 200 day moving average is $0.68. The stock has a market cap of $49.49 million, a price-to-earnings ratio of -151.80 and a beta of 1.15.

About Burcon NutraScience

(Get Rating)

Burcon NutraScience Corporation, together with its subsidiary, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include CLARISOY, a soy protein for use in sports nutrition beverages, dairy alternative yogurts and cheeses, powdered beverage mixes, coffee creamers, and other foods and nutritional products; and Peazazz, a pea protein for dairy alternative products, such as protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods, as well as dry blended and ready-to-drink beverages.

Recommended Stories

  • Get a free copy of the StockNews.com research report on Burcon NutraScience (BUROF)
  • 3 Low Beta Defensive Stocks for a Tough Market
  • It Could Be a September to Remember for These 3 Stocks
  • Peak Inflation Sets the Bottom for Brinker International Stock
  • Can Roblox Reverse its Falling Bookings Amid Rising Engagements
  • Broadcom Bounces From Institutional Bottom

Receive News & Ratings for Burcon NutraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment